Psilocybin-Assisted Therapy Aids Symptoms of Major Depressive Disorder
THURSDAY, Sept. 25, 2025 -- Psilocybin-assisted therapy (PAT) shows long-term safety and efficacy for treating symptoms of major depressive disorder (MDD), according to a study published online Sept. 4 in the Journal of Psychedelic Studies.
Alan K. Davis, from The Ohio State University in Columbus, and colleagues assessed the long-term safety and efficacy of PAT for MDD. The analysis included 18 participants completing long-term follow-up from a previous randomized controlled trial.
The researchers found significant and sustained reductions in depression, with 67 percent in remission for at least five years posttreatment. There were also improvements in anxiety and functional impairment. Qualitative analysis of interviews revealed lasting positive changes in mindset, emotional health, and relationships. Participants also reported improved empathy, self-acceptance, and improved interpersonal relationships. There were no severe adverse events reported.
“Five years later, most people continued to view this treatment as safe, meaningful, important, and something that catalyzed an ongoing betterment of their life,” Davis said in a statement. "It's important for us to understand the details of what comes after treatment. I think this is a sign that regardless of what the outcomes are, their lives were improved because they participated in something like this."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
Suicidal Ideation Risk Elevated for Patients With Atopic Eczema
WEDNESDAY, Sept. 17, 2025 -- Patients with atopic eczema (AE) have an increased risk for suicidal ideation (SI), according to a study presented at the European Academy of...
Parental Diseases of Despair Linked to Suicidal Events in Offspring
MONDAY, Sept. 15, 2025 -- Parental diseases of despair (DoD; i.e., substance use disorder, alcohol-related disease, or suicidal behavior) are associated with suicidal events (SE)...
Adjunctive Ketogenic Diet Beneficial for Major Depressive Disorder
WEDNESDAY, Sept. 10, 2025 -- A ketogenic diet (KD) is a feasible adjunctive therapy and is associated with improvements in depression symptoms among young adults with major...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.